Combination therapies targeting PD-1, TIM-3, and LAG-3
US11939380B2 · kind B2 · utility
0Cited by
7References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2018 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | May 26, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to combination therapies targeting two or all of PD-1, TIM-3, and LAG-3 using antibodies specific for these targets in patients who are in need of enhanced immunity. Also included in the disclosure are compositions useful in the therapies. The therapies are useful in treating diseases such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.